BiotechTube

60 mg ulixacaltamide + Placebo

Phase 3Recruiting
2 views this week 0 watching⚡ Active📊Featured in Mid-Cap Catalyst Watch
Interest: 44/100
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Essential Tremor

Conditions

Essential Tremor

Trial Timeline

Nov 2, 2023 → Dec 1, 2026

NCT ID
NCT06087276

About 60 mg ulixacaltamide + Placebo

60 mg ulixacaltamide + Placebo is a phase 3 stage product being developed by Praxis Precision Medicines for Essential Tremor. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06087276. Target conditions include Essential Tremor.

What happened to similar drugs?

15 of 20 similar drugs in Essential Tremor were approved

Approved (15) Terminated (2) Active (5)
✅Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
✅Anagre Cap.YuhanApproved
✅olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
✅olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
✅Atenolol + olmesartan medoxomilDaiichi SankyoApproved
✅Arotinolol Hydrochloride + Metoprolol succinate sustained-release tabletSumitomo PharmaApproved
✅Aliskiren + Hydrochlorothiazide + AmlodipineNovartisApproved

Hype Score Breakdown

Clinical
17
Activity
15
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06087276Phase 3Recruiting

Competing Products

20 competing products in Essential Tremor

See all competitors
ProductCompanyStageHype Score
L04RD1 + L04TD3CelltrionPhase 1
29
Azilsartan MedoxomilCelltrionPre-clinical
26
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mgCelltrionPhase 3
40
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgYuhanApproved
47
Anagre Cap.YuhanApproved
43
Telmisartan/Amlodipine/Chlorthalidone(Truset)YuhanPre-clinical
30
olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo + olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil/hydrochlorothiazide tablets + olmesartan medoxomil/hydrochlorothiazide tabletsDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + losartan + hydrochlorothiazide, if necessaryDaiichi SankyoPhase 3
40
CS8635 20/5/12.5mg and placebo + Olmetec® Plus 20/12.5mg and placeboDaiichi SankyoPhase 3
40
CS-3150 + olmesartan medoxomilDaiichi SankyoPre-clinical
26
olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo + Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + hydroclororthiazide + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipine + olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
40
Olmesartan medoxomil + Atenolol + Hydrochlorothiazide + olmesartan medoxomil + atenololDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
43
CS-3150 + EplerenoneDaiichi SankyoPhase 3
40
olmesartan medoxomil + losartan potassiumDaiichi SankyoPhase 3
40
Olmesartan medoxomil 40 mg - Amlodipine 10 mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg + Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg + OLM 40mg-AML 10mg-Hydrochlorothiazide 25mgDaiichi SankyoPhase 3
40
olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessaryDaiichi SankyoApproved
43
Olmesartan medoxomil + Losartan + Furosemide oral tabletsDaiichi SankyoPhase 3
40
olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets + olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mgDaiichi SankyoPhase 3
40
olmesartan medoxomil + amlodipineDaiichi SankyoPhase 3
40